Michael Yee
Stock Analyst at Jefferies
(3.01)
# 1,515
Out of 4,996 analysts
78
Total ratings
43.4%
Success rate
12.56%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALXO ALX Oncology Holdings | Upgrades: Buy | $2 → $3 | $1.87 | +60.43% | 5 | Mar 6, 2025 | |
| KOD Kodiak Sciences | Upgrades: Buy | $20 | $15.80 | +26.58% | 3 | Dec 9, 2024 | |
| BIIB Biogen | Downgrades: Hold | $250 → $180 | $137.37 | +31.03% | 5 | Dec 9, 2024 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Buy | $500 → $550 | $385.74 | +42.58% | 4 | Dec 9, 2024 | |
| AMGN Amgen | Maintains: Buy | $380 | $272.98 | +39.20% | 5 | Nov 12, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $40 → $45 | $13.95 | +222.58% | 2 | Nov 1, 2024 | |
| MRNA Moderna | Maintains: Hold | $65 → $55 | $24.49 | +124.58% | 8 | Oct 15, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $35 | $17.51 | +99.89% | 1 | Oct 8, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $40 | $15.20 | +163.16% | 1 | Sep 13, 2024 | |
| AXON Axon Enterprise | Initiates: Buy | $385 | $708.84 | -45.69% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1.4 → $10 | $3.20 | +212.50% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $3 | $8.08 | -62.87% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $30 | $22.97 | +30.61% | 2 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $20 | $16.00 | +25.00% | 8 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 → $20 | $38.75 | -48.39% | 3 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $63 → $75 | $9.79 | +666.09% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $2.98 | +906.71% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $34.02 | +91.06% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,875 → $1,125 | $12.31 | +9,038.91% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 → $30 | $2.65 | +1,032.08% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $30 | $9.41 | +218.81% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $120 | $24.73 | +385.24% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $70 → $75 | $19.30 | +288.60% | 2 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $32.68 | -8.20% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $77 | $18.34 | +319.85% | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $112.10 | - | 3 | Jan 26, 2018 |
ALX Oncology Holdings
Mar 6, 2025
Upgrades: Buy
Price Target: $2 → $3
Current: $1.87
Upside: +60.43%
Kodiak Sciences
Dec 9, 2024
Upgrades: Buy
Price Target: $20
Current: $15.80
Upside: +26.58%
Biogen
Dec 9, 2024
Downgrades: Hold
Price Target: $250 → $180
Current: $137.37
Upside: +31.03%
Vertex Pharmaceuticals
Dec 9, 2024
Upgrades: Buy
Price Target: $500 → $550
Current: $385.74
Upside: +42.58%
Amgen
Nov 12, 2024
Maintains: Buy
Price Target: $380
Current: $272.98
Upside: +39.20%
Denali Therapeutics
Nov 1, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $13.95
Upside: +222.58%
Moderna
Oct 15, 2024
Maintains: Hold
Price Target: $65 → $55
Current: $24.49
Upside: +124.58%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $17.51
Upside: +99.89%
Oruka Therapeutics
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $15.20
Upside: +163.16%
Axon Enterprise
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $708.84
Upside: -45.69%
Mar 27, 2024
Upgrades: Buy
Price Target: $1.4 → $10
Current: $3.20
Upside: +212.50%
Mar 15, 2024
Downgrades: Hold
Price Target: $16 → $3
Current: $8.08
Upside: -62.87%
Dec 8, 2023
Downgrades: Hold
Price Target: $75 → $30
Current: $22.97
Upside: +30.61%
Oct 25, 2023
Downgrades: Hold
Price Target: $60 → $20
Current: $16.00
Upside: +25.00%
Oct 25, 2023
Upgrades: Buy
Price Target: $8 → $20
Current: $38.75
Upside: -48.39%
Jan 6, 2023
Upgrades: Buy
Price Target: $63 → $75
Current: $9.79
Upside: +666.09%
Nov 15, 2021
Initiates: Buy
Price Target: $30
Current: $2.98
Upside: +906.71%
Mar 2, 2021
Initiates: Buy
Price Target: $65
Current: $34.02
Upside: +91.06%
Mar 2, 2021
Downgrades: Hold
Price Target: $1,875 → $1,125
Current: $12.31
Upside: +9,038.91%
Feb 12, 2021
Downgrades: Hold
Price Target: $40 → $30
Current: $2.65
Upside: +1,032.08%
Feb 12, 2021
Upgrades: Buy
Price Target: $15 → $30
Current: $9.41
Upside: +218.81%
Nov 6, 2020
Downgrades: Hold
Price Target: $120
Current: $24.73
Upside: +385.24%
Oct 12, 2020
Upgrades: Buy
Price Target: $70 → $75
Current: $19.30
Upside: +288.60%
Sep 14, 2020
Initiates: Buy
Price Target: $30
Current: $32.68
Upside: -8.20%
Nov 8, 2018
Assumes: Buy
Price Target: $77
Current: $18.34
Upside: +319.85%
Jan 26, 2018
Upgrades: Buy
Price Target: n/a
Current: $112.10
Upside: -